Target intelligence / Profile preview

Mature Dendritic Cells (mDCs)

Target
mDCs
Molecular classification
Antigen-Presenting Cell, Immune Cell, Hematopoietic Cell
01

Overview

Mature dendritic cells are central orchestrators in anti-tumor immunity due to their unique capacity for efficient processing and presentation of tumor-associated antigens—especially through cross-presentation pathways—to activate both helper and cytotoxic arms of adaptive immunity. Their function is critical not only under physiological conditions but also as a therapeutic target/intervention point within cancer immunotherapy strategies such as personalized vaccines using autologous matured/pulsed dendritic cells.

Other names
Activated Dendritic CellsAntigen-Presenting Dendritic Cells
02

Mechanism of action

Mature DCs present tumor-associated antigens via MHC class I and II molecules to activate CD8+ and CD4+ T cells, respectively, leading to tumor cell lysis and immune response amplification. They also secrete cytokines to modulate the immune microenvironment.

03

Biological functions

Antigen presentationT cell activationCytokine productionImmune response initiationCross-presentation
04

Disease associations

CancerAutoimmunityInfectionInflammation
05

Safety considerations

Cytokine release syndromeAutoimmunityOff-target effects of DC-based therapiesTumor escape mechanismsLimited efficacy in some patients
06

Interacting drugs

GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)

3 more in the full profile.

07

Biomarkers

CD80 expressionCD86 expressionMHC class I expressionMHC class II expressionIntratumoral DC densityCCR7 expression

Beyond the preview

Go deeper on Mature Dendritic Cells (mDCs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mature Dendritic Cells (mDCs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call